Related Articles
Use of CA15‑3 for screening breast cancer: An antibody‑lectin sandwich assay for detecting glycosylation of CA15‑3 in sera
Correlation between salivary and serum CA15‑3 concentrations in patients with breast cancer
DETECTION AND COMPARISON OF A 90-KD GLYCOPROTEIN TUMOR-ASSOCIATED ANTIGEN-SPECIFIC IMMUNE-COMPLEXES WITH CEA AND CA15-3 IN BREAST-CANCER
Circulating antibodies to p16 protein‑derived peptides in breast cancer
Elevation of serum CEA and CA15‑3 levels during antitumor therapy predicts poor therapeutic response in advanced breast cancer patients